Risk factors for high-dose cytarabine neurotoxicity: an analysis of a cancer and leukemia group B trial in patients with acute myeloid leukemia (Q28319875)

From Wikidata

Jump to navigation Jump to search

scientific article (publication date: June 1992)

edit

Language	Label	Description	Also known as
English	Risk factors for high-dose cytarabine neurotoxicity: an analysis of a cancer and leukemia group B trial in patients with acute myeloid leukemia	scientific article (publication date: June 1992)

Statements

instance of

scholarly article

0 references

title

Risk factors for high-dose cytarabine neurotoxicity: an analysis of a cancer and leukemia group B trial in patients with acute myeloid leukemia (English)

0 references

main subject

neurotoxicity

1 reference

based on heuristic

inferred from title

leukemia

1 reference

based on heuristic

inferred from title

cytarabine

1 reference

based on heuristic

inferred from title

acute myeloid leukemia

1 reference

based on heuristic

inferred from title

toxic encephalopathy

1 reference

based on heuristic

inferred from title

author name string

E. H. Rubin

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1588374

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1588374

retrieved

12 October 2022

J. W. Andersen

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1588374

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1588374

retrieved

12 October 2022

D. T. Berg

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1588374

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1588374

retrieved

12 October 2022

C. A. Schiffer

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1588374

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1588374

retrieved

12 October 2022

R. J. Mayer

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1588374

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1588374

retrieved

12 October 2022

R. M. Stone

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1588374

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1588374

retrieved

12 October 2022

language of work or name

English

0 references

publication date

June 1992

0 references

full work available at URL

http://intl.jco.org/cgi/content/abstract/10/6/948

online access status

open access

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1588374

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1588374

retrieved

12 October 2022

published in

Journal of Clinical Oncology

0 references

volume

10

0 references

issue

6

0 references

page(s)

948-53

0 references

Identifiers

DOI

10.1200/JCO.1992.10.6.948

0 references

PubMed publication ID

1588374

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28319875&oldid=1748695649"